Figure 1. Peripheral blood eosinophilia, 1000XFigure 1.  Peripheral blood eosinophilia, 1000X
Figure 2. Bone marrow aspirate field, 1000XFigure 2.  Bone marrow aspirate field, 1000X
Figure 3. Bone marrow core biopsy, low power (20X)Figure 3.  Bone marrow core biopsy, low power (20X)
Figure 4. Bone marrow core biopsy, high power (400X)Figure 4. Bone marrow core biopsy, high power (400X)
Figure 5. Core biopsy, CD34 (100X)Figure 5.  Core biopsy, CD34 (100X)
Figure 6) Core biopsy, CD79a (400X)Figure 6) Core biopsy, CD79a (400X)
Figure 7) Flow cytometry dot plots showing a population of B-lymphoblasts (red) with expression of CD34, CD19, CD10, and aberrant expression of CD13 and CD33Figure 7) Flow cytometry dot plots showing a population of B-lymphoblasts (red) with expression of CD34, CD19, CD10, and aberrant expression of CD13 and CD33